JP6035578B2 - 乳酸菌、それを含む組成物及びそれらの使用 - Google Patents

乳酸菌、それを含む組成物及びそれらの使用 Download PDF

Info

Publication number
JP6035578B2
JP6035578B2 JP2015088066A JP2015088066A JP6035578B2 JP 6035578 B2 JP6035578 B2 JP 6035578B2 JP 2015088066 A JP2015088066 A JP 2015088066A JP 2015088066 A JP2015088066 A JP 2015088066A JP 6035578 B2 JP6035578 B2 JP 6035578B2
Authority
JP
Japan
Prior art keywords
composition
individual
lactic acid
acid bacterium
functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015088066A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015213501A (ja
JP2015213501A5 (enExample
Inventor
英傑 蔡
英傑 蔡
偉賢 劉
偉賢 劉
堅甫 廖
堅甫 廖
智捷 許
智捷 許
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Yang Ming Chiao Tung University
Original Assignee
National Yang Ming Chiao Tung University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US14/259,442 external-priority patent/US10967013B2/en
Priority claimed from US14/690,502 external-priority patent/US10188684B2/en
Application filed by National Yang Ming Chiao Tung University filed Critical National Yang Ming Chiao Tung University
Publication of JP2015213501A publication Critical patent/JP2015213501A/ja
Publication of JP2015213501A5 publication Critical patent/JP2015213501A5/ja
Application granted granted Critical
Publication of JP6035578B2 publication Critical patent/JP6035578B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/46—Drugs for disorders of the endocrine system of the suprarenal hormones for decreasing, blocking or antagonising the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/25—Lactobacillus plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Psychiatry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
JP2015088066A 2014-04-23 2015-04-23 乳酸菌、それを含む組成物及びそれらの使用 Active JP6035578B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US14/259,442 2014-04-23
US14/259,442 US10967013B2 (en) 2014-04-23 2014-04-23 Lactic acid bacterium for prophylaxis or treatment of a stress-induced disorder and a composition containing the same
US14/690,502 2015-04-20
US14/690,502 US10188684B2 (en) 2015-04-20 2015-04-20 Method for preventing or treating functional gastrointestinal disorder by lactic acid bacterium

Publications (3)

Publication Number Publication Date
JP2015213501A JP2015213501A (ja) 2015-12-03
JP2015213501A5 JP2015213501A5 (enExample) 2016-01-28
JP6035578B2 true JP6035578B2 (ja) 2016-11-30

Family

ID=53008330

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015088066A Active JP6035578B2 (ja) 2014-04-23 2015-04-23 乳酸菌、それを含む組成物及びそれらの使用

Country Status (5)

Country Link
EP (1) EP2937424B1 (enExample)
JP (1) JP6035578B2 (enExample)
CN (1) CN105002109B (enExample)
ES (1) ES2624673T3 (enExample)
PL (1) PL2937424T3 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6933358B2 (ja) * 2016-04-06 2021-09-08 東海漬物株式会社 美肌促進剤
WO2018014225A1 (en) * 2016-07-19 2018-01-25 Bened Biomedical Co., Ltd. Method for preventing or treating movement disorders with lactic acid bacterium
KR20180019474A (ko) 2016-08-16 2018-02-26 주식회사 엠디헬스케어 락토바실러스 플란타룸 유래 소포를 포함하는 정신질환 예방 또는 치료용 조성물
CN107050062A (zh) * 2016-11-08 2017-08-18 江西益盟科技有限公司 治疗便秘的乳酸菌组合物及其制备方法
CN110475853A (zh) * 2017-01-13 2019-11-19 益福生医股份有限公司 新颖乳酸菌及其应用
KR102089836B1 (ko) * 2017-03-15 2020-03-16 (주)바이오일레븐 트립토판분해효소 음성균과 인터페론 감마 형성을 유도하는 균주를 이용한 염증성 질환 예방 및 치료용 약학적 조성물 또는 이를 이용한 치료방법
CN106906165B (zh) * 2017-04-25 2020-07-24 重庆第二师范学院 一种植物乳杆菌及其在制备预防便秘的食品中的应用
CN107267416A (zh) * 2017-07-05 2017-10-20 重庆第二师范学院 植物乳杆菌ys2及其在制备预防便秘的食品中的应用
WO2019119261A1 (en) * 2017-12-19 2019-06-27 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
ES2987106T3 (es) * 2017-12-19 2024-11-13 Int N&H Denmark Aps Probióticos para la salud cognitiva y mental
CA3089187C (en) 2018-02-02 2024-10-29 Kobiolabs, Inc. LACTOBACILLUS PLANTARUM KBL396 STRAIN AND ITS USE
CN111035661A (zh) * 2018-10-15 2020-04-21 深圳市华大农业应用研究院 植物乳杆菌的用途
TWI731279B (zh) * 2018-11-21 2021-06-21 葡萄王生技股份有限公司 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途
ES2763350B2 (es) * 2018-11-28 2020-10-13 Consejo Superior Investigacion Cepa de christensenella minuta y uso de la misma
CA3120942A1 (en) * 2018-12-06 2020-06-11 Dupont Nutrition Biosciences Aps Probiotics for cognitive and mental health
JP7433327B2 (ja) * 2019-01-28 2024-02-19 ベネド バイオメディカル カンパニー リミテッド 対象の運動疲労を軽減するための組成物
US20210353692A1 (en) * 2019-02-01 2021-11-18 Bened Biomedical Co., Ltd. Method for preventing or treating abnormal emotion or behavior in non-human animal by lactic acid bacterium
KR102866368B1 (ko) * 2019-02-01 2025-09-29 엥스티튀 나쇼날 드 르쉐르슈 푸흐 라그리컬튀흐, 랄리망따씨옹 에 랑비허른망 내장 통증의 예방 및/또는 치료를 위한 락토콕커스 락티스 균주
KR102148707B1 (ko) * 2019-02-22 2020-08-31 한국식품연구원 우울증 및 불안장애의 예방, 개선 또는 치료 효능을 갖는 김치 유산균 락토바실러스 사케아이
CN115052969A (zh) * 2020-02-06 2022-09-13 李旺祚 用于预防或治疗雷特氏综合征的乳酸菌组合物
US20230330163A1 (en) * 2020-03-25 2023-10-19 Bened Biomedical Co., Ltd. Method for reducing behavioral abnormalities
US20230390347A1 (en) * 2020-10-22 2023-12-07 Wang-Tso Lee Lactic acid bacterium for treatment of aromatic l-amino acid decarboxylase deficiency
WO2022131192A1 (ja) * 2020-12-16 2022-06-23 株式会社明治 脳組織の炎症改善用組成物
CN113215018A (zh) * 2021-02-04 2021-08-06 郑州大学 一株植物乳杆菌植物亚种及其在豆粕和北艾混合发酵中的应用
CN113564084A (zh) * 2021-08-13 2021-10-29 华东理工大学 植物乳杆菌x7022在预防和治疗便秘上的应用
TWI810645B (zh) * 2021-09-06 2023-08-01 景岳生物科技股份有限公司 乳桿菌組合物及其改善抗生素造成之焦慮症的用途
CN116536434A (zh) * 2022-10-25 2023-08-04 菏泽学院 特异性检测、鉴别检测鼠李糖乳杆菌的引物探针及其应用
CN120282792A (zh) * 2022-10-28 2025-07-08 科·汉森有限公司 用于解决肠易激综合征症状的植物乳植杆菌
CN117143760B (zh) * 2023-07-12 2024-09-20 西南大学 一株能促进5-htp分泌及缓解抑郁的鼠李糖乳酪杆菌ky16及其应用
KR102741129B1 (ko) * 2023-11-07 2024-12-11 농업회사법인 고려홍삼원 주식회사 락토바실러스 플란타룸 ckh-01 균주를 포함하는 스트레스 완화 및 수면개선용 프로바이오틱스 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5725853A (en) * 1994-10-18 1998-03-10 Pioneer Hi-Bred International, Inc. 4 strain direct-fed microbial
US20050158294A1 (en) * 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8669267B2 (en) * 2008-08-21 2014-03-11 Suntory Holdings Limited Pharmaceutical, food or beverage having inhibitory activity on serotonin transporter

Also Published As

Publication number Publication date
CN105002109B (zh) 2018-09-14
CN105002109A (zh) 2015-10-28
JP2015213501A (ja) 2015-12-03
EP2937424A1 (en) 2015-10-28
EP2937424B1 (en) 2017-03-29
PL2937424T3 (pl) 2017-09-29
ES2624673T3 (es) 2017-07-17

Similar Documents

Publication Publication Date Title
JP2015213501A (ja) 乳酸菌、それを含む組成物及びそれらの使用
Visñuk et al. Neuroprotective effects associated with immune modulation by selected lactic acid bacteria in a Parkinson's disease model
KR101813881B1 (ko) 락트산 박테리아, 이를 함유하는 조성물 및 그의 용도
Ng et al. A meta-analysis of the use of probiotics to alleviate depressive symptoms
Andreasen et al. Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects
Zoll et al. Fecal microbiota transplantation from high caloric-fed donors alters glucose metabolism in recipient mice, independently of adiposity or exercise status
Corbitt et al. A systematic review of probiotic interventions for gastrointestinal symptoms and irritable bowel syndrome in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME)
TW201540835A (zh) 用於預防或治療壓力引發之失調的乳酸菌及包含該乳酸菌之組成物
EP4081231A1 (en) Compositions comprising microbes and methods of use and making thereof
CN117018040B (zh) 动物双歧杆菌乳亚种在神经保护中的应用
Kim et al. Investigation of memory-enhancing effects of Streptococcus thermophilus EG007 in mice and elucidating molecular and metagenomic characteristics using nanopore sequencing
US11058733B2 (en) Active substances of Bifidobacterium lactis GKK2, composition comprising the same and method of promoting longevity using the same
US12419920B2 (en) Bifidobacterium longum NCIMB 41676
Tanner et al. Current and future uses of probiotics
Roos et al. Therapeutic value of Lactobacillus gasseri 345A in chronic constipation
US20200289588A1 (en) Bifidobacterium longum ncimb 41676
WO2022192854A1 (en) Methods to induce biopterin and related metabolites
CN118831101A (zh) 一株益生菌在制备防治帕金森病便秘的产品中的应用
Chen et al. The human microbiota and its therapeutic options
US11813296B2 (en) Bacillus subtilis probiotics and methods of use for improving immune function, hormonal status, and physical performance
Ivanova et al. Human Gut Microbiome as an Indicator of Human Health
Dean Cultivating Excellence: A Literature Review on Harnessing the Power of the Gut Microbiome for Athletic Performance
Kirchgessner The role of the microbiota and potential for dietary intervention in chronic fatigue syndrome
Moore Exploring the effects of six weeks of resistance training on the fecal microbiome of older adult males
CN121379884A (zh) 一株用于治疗慢性脑缺血的嗜酸乳杆菌

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151208

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160630

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20161005

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20161007

R150 Certificate of patent or registration of utility model

Ref document number: 6035578

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

Free format text: JAPANESE INTERMEDIATE CODE: R313111

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250